Reaction Details |
| Report a problem with these data |
Target | Galectin-3 |
---|
Ligand | BDBM50591135 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_2199430 (CHEMBL5111946) |
---|
Kd | >100000±n/a nM |
---|
Citation | Zetterberg, FR; MacKinnon, A; Brimert, T; Gravelle, L; Johnsson, RE; Kahl-Knutson, B; Leffler, H; Nilsson, UJ; Pedersen, A; Peterson, K; Roper, JA; Schambye, H; Slack, RJ; Tantawi, S Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease. J Med Chem65:12626-12638 (2022) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Galectin-3 |
---|
Name: | Galectin-3 |
Synonyms: | LEG3_HUMAN | LGALS3 | MAC2 |
Type: | Enzyme |
Mol. Mass.: | 26156.54 |
Organism: | Homo sapiens (Human) |
Description: | P17931 |
Residue: | 250 |
Sequence: | MADNFSLHDALSGSGNPNPQGWPGAWGNQPAGAGGYPGASYPGAYPGQAPPGAYPGQAPP
GAYPGAPGAYPGAPAPGVYPGPPSGPGAYPSSGQPSATGAYPATGPYGAPAGPLIVPYNL
PLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNN
WGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDI
DLTSASYTMI
|
|
|
BDBM50591135 |
---|
n/a |
---|
Name | BDBM50591135 |
Synonyms: | CHEMBL5208259 |
Type | Small organic molecule |
Emp. Form. | C33H40F2N6O8S |
Mol. Mass. | 718.768 |
SMILES | [H][C@]1(O[C@H](COC)[C@H](OC)[C@@H]([C@H]1OC)n1cc(nn1)-c1cccc(F)c1)S[C@@H]1O[C@H](CO)[C@H](OC)[C@@H]([C@H]1OC)n1cc(nn1)-c1cccc(F)c1 |r| |
Structure |
|